Access cutting-edge kidney transplant treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access kidney transplant specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney transplant treatment provided free
This is a pediatric kidney transplant study comparing the safety and efficacy of an immunosuppressive regimen of belatacept and sirolimus to tacrolimus and Mycophenolate Mofetil (MMF). Two hundred participants will be randomized (1:1) to one of two groups within 24 hours following the transplant procedure. The duration of the study from time of transplant to the primary endpoint is 12-24 months.
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this kidney transplant clinical trial in Chicago, IL
If you're searching for kidney transplant treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.